Clinical Evidence: GLP-1s and Sperm Health Recent research from the AUA 2025 study 3 provides compelling evidence that GLP-1 receptor agonists (GLP-1 RAs), like semaglutide, have a significant connection in improving sperm count in overweight and obese men
Possible side effects may include injection site redness, mild tenderness, temporary headache, fatigue, nausea, or localized irritation
Soboba Weight Loss Clinics emphasizes medical supervision, patient education, and responsible treatment planning
Obici S, Feng Z, Morgan K, Stein D, Karkanias G, Rossetti L: Central administration of oleic acid inhibits glucose production and food intake
GLP-1 agonists are changing obesity care GLP-1 agonists are now going beyond diabetes care
SeekPeptides members access detailed mechanism guides, dosing calculators, and evidence-based protocols that help researchers understand exactly how peptides like tirzepatide interact with the body